Gelatin Particles
Gelatin Particles - Related Videos
07:06
Particle Agglutination Method for Poliovirus Identification
0 Views •
2011
A recently developed novel particle agglutination (PA) assay utilizing virus receptor molecule allowed a rapid and easy identification of poliovirus (PV). In this article, we will show the procedure for the PA assay for PV identification.
09:11
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
0 Views •
Cited by 10 •
2016
We present a facile method to fabricate a biodegradable gelatin-based drug release platform that is magneto-thermally responsive. This was achieved by incorporating superparamagnetic iron oxide nanoparticles and poly(N-isopropylacrylamide-co-acrylamide) within a spherical gelatin micro-network crosslinked by genipin, in conjunction with an alternating magnetic field application system.
03:37
Subatomic Particles
0 Views •
2020
Dalton was only partially correct about the particles that make up matter. All matter is composed of atoms, and atoms are composed of three smaller subatomic particles: protons, neutrons, and electrons. These three particles account for the mass and the charge of an atom. The Discovery of the Electron The first clue about the subatomic structure came at the end of the 19th century when J.J. Thomson discovered the electron using a cathode ray tube. This apparatus consisted of a sealed glass...
07:33
A Novel Culture Model for Human Pluripotent Stem Cell Propagation on Gelatin in Placenta-conditioned Media
0 Views •
Cited by 5 •
2015
This protocol provides a simple and efficient way to propagate human pluripotent stem cells (hPSCs) using only conditioned media derived from the human placenta in a gelatin-coated dish without additional exogenous supplementation or hPSC-specific synthetic substrata.
08:35
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
0 Views •
Cited by 28 •
2012
Type B gelatin-based engineered nanovectors system (GENS) was developed for systemic gene delivery and transfection in the treatment of pancreatic cancer. By modification with epidermal growth factor receptor (EGFR) specific peptide on the surface of nanparticles, they could target on EGFR receptor and release plasmid under reducing environment, such as high intracellular glutathione concentrations.
FAQs
Particle size and cross-linking influence how stable the particles remain, how quickly they degrade, and how cargo is released. Greater control over these features can help align release behavior with an intended immune or therapeutic use. In infection research, these variables are therefore important when designing particles that retain their contents long enough to act at infected tissues without unnecessary systemic exposure.
The porous structure provides space for incorporating biological or therapeutic cargo, including antigens and drugs. Its interaction with the surrounding gelatin matrix affects how those molecules remain associated with the particle and become available over time. This makes porosity relevant when researchers seek controlled delivery rather than immediate dispersal of the entire payload.
Because the particle surface can be modified, researchers can adjust how gelatin particles interact with their surroundings and with biological targets. In immunology, surface changes may support more deliberate antigen-delivery designs, while in infection studies they can contribute to strategies intended to concentrate treatment in affected tissues. The surface is therefore a key design feature alongside size and cross-linking.
A design workflow can involve selecting gelatin as the matrix, incorporating an antigen, and then tuning particle size, cross-linking, or surface properties to influence stability and release. The resulting system can be evaluated for its capacity to deliver antigen to immune cells, which may internalize particles through phagocytosis. These design choices connect material properties with the desired immune outcome.
Gelatin particles can carry therapeutic molecules intended for antimicrobial strategies and controlled treatment of infected tissues. Their biodegradable matrix and adjustable release-related properties may help retain cargo within a delivery system while limiting broader exposure. This approach is relevant when infection research seeks to combine localized treatment with a material that can eventually degrade.
These systems can be used to examine how immune cells encounter and internalize particulate cargo, how antigen delivery influences immune activation, and how therapeutic molecules are presented in infection settings. By varying particle design, researchers can relate size, stability, degradation, or release to biological responses. The resulting comparisons support studies of host-pathogen interactions and delivery-system performance.